We predicted that the proteins BCL2L1, MAPK14, CTNNB1, TP53, EIF4EBP1, HIF1a, HMGB, and mTOR would be potential direct targets of Tan IIA in the treatment of rheumatoid arthritis. Here, BCL2L1 is linked to rheumatoid arthritis.